~~<i id='8DB886361C'><strike id='8DB886361C'><tt id='8DB886361C'><pre id='8DB886361C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：hotspot 2025-10-02 20:47:56 - browse：794

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history.

This week Biogen said it would no longer sell or study the medicine, which first won approval in 2021, ending an era for one of biotech’s storied companies and leaving the rest of the industry to piece together the lessons of a would-be blockbuster that never took off.

STAT reporters took a stab at the Aduhelm legacy — for biotech, Biogen, and Alzheimer’s research — on a recent episode of the Readout LOUD. Here’s an edited transcript of that conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Readout Newsletter: Zepbound, Valneva's vaccine, and more

knowledge

hotspot

knowledge

entertainment

explore

LeonNeal/GettyImagesLONDON—Clinicaltrialshaveshownthatlifestyleprograms—whichincludediet,exercise,an

WSS

Why the quest to eradicate polio has stumbled

Senate bill would ban some hospital facility fees

Carbon Health diabetes program, a test of data

First transplant of an entire human eye performed

Healthy food access boosts outcomes in two studies

Chamber of Commerce, DOJ clash in court over drug prices

hotspot

Wikipedia

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

A letter from the executive editor: STAT UnitedHealth investigation

Peter Hotez and the public health issue of online harassment

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Affirmative action in medical school literally saved lives

Transgender sports debate: Physicians say bans are health issue

Dobbs anniversary: the lost opportunity of abortion as health care

After decades in use, heart stents finally beat placebo

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

David Liu startup to focus on CRISPR delivery

hotspot

Akili changes sales model for its ADHD video game treatment

FDA reorg will put new emphasis on investigations, sources say

Senate bill would ban some hospital facility fees

Medical school prerequisites are outdated

Today's health inequities arise from racist U.S. history, say experts

Patients, doctors press FTC to beef up hospital merger scrutiny

knowledge

entertainment

entertainment

explore